Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Aquinox Pharmaceuticals (AQXP) IPO Prices at $11
-
Aquinox Pharmaceuticals Prices Initial Public Offering
-
Canaccord Genuity Downgrades Numerex (NMRX) to Hold
-
Notable Analyst Rating Changes 03/06: (BIIB) (COG) (HA) Upgraded; (AUXL) (LOV) (ARTC) Downgraded
-
Canaccord Genuity Downgrades Spark Networks (LOV) to Hold
-
Synageva BioPharma (GEVA) Prices 2M Share Offering at $105.75
-
Canaccord Genuity Maintains Buy on Thoratec (THOR) Despite Negative Headlines
-
Amber Road (AMBR) Sees IPO Price of $10.50 - $12.50
-
Veeva Systems (VEEV) Bullish Stance Maintained at Canaccord Genuity
-
Canaccord Genuity Starts Egalet Ltd (EGLT) at Buy
-
UPDATE: Canaccord Genuity Upgrades Nokia (NOK) to Buy
-
Opower (OPWR) Files $100M IPO
-
Notable Analyst Rating Changes 03/03: (NOK) (KATE) (TDS) Upgraded; (ADSK) (AZN) (RIO) Downgraded
-
Canaccord Genuity Starts Sequential Brands (SQBG) at Buy
-
Restaurant Order Platform GrubHub (GRUB) Files $100M IPO
-
SodaStream's (SODA) Q4 Challenges Likely to Carry Into Q1; Canaccord Maintains at 'Hold'
-
Canaccord Genuity Upgrades SciQuest (SQI) to Buy
-
Streetinsider.com's Hot Lunchtime Reads 02/25: (TSLA) (ITMN) (EOG) (RARE)
-
UPDATE: Canaccord Genuity Starts Ultragenyx Pharma (RARE) at Buy
-
UPDATE: Canaccord Genuity Starts Cara Therapeutics (CARA) at Buy
-
Notable Analyst Rating Changes 02/25: (KGC) (ED) (EOG) Upgraded; (PAAS) (VVUS) (BAS) Downgraded
-
Canaccord Genuity Upgrades Kinross Gold (KGC) to Buy
-
Myoscience to Present at the Canaccord Genuity Musculoskeletal Conference
-
Canaccord Genuity Downgrades RF Micro Devices (RFMD) to Hold
-
Canaccord Genuity Upgrades Golden Star Resources (GSS) to Hold
-
GT Advanced Tech (GTAT) Target Lifted to $21 at Canaccord Genuity on Apple Visibility
-
Canaccord Genuity Starts Lifetime Brands (LCUT) at Buy
-
Notable Mergers and Acquisitions of the Day 02/20: (FB) (PRAA) (SWY) (XWES)
-
Cytokinetics (CYTK) Prices 4.38M Common Offering at $8/Share
-
World Energy Solutions (XWES) to Review Strategic Alternatives
-
World Energy Solutions Undertakes Review of Board Structure and Other Strategic Matters
-
Canaccord Genuity Starts HEICO (HEI) at Buy
-
Versartis, Inc. Files $80M IPO
-
Borderfree Files Registration Statement for Proposed Initial Public Offering
-
Borderfree (BRDR) Files $86.25M IPO
-
Cogent Communications (CCOI) a 'Buy' Ahead of Q4 Results; 20%+ Dividend Growth to Continue
-
GT Advanced Tech (GTAT): Apple (AAPL) Serious About Sapphire Cover Glass iPhone, Says Canaccord Genuity
-
Advaxis to Participate in Canaccord Genuity Orphan Drug One-on-One Day
-
Canaccord Genuity Upgrades Veeco Instruments Inc. (VECO) to Hold
-
Canaccord Genuity Upgrades Universal Display (OLED) to Hold
-
Notable Analyst Rating Changes 02/14: (SSYS) (DFS) (CMA) Upgraded; (MAT) (DISH) (ARO) Downgraded
-
Canaccord Genuity Downgrades Agnico-Eagle Mines Ltd. (AEM) to Hold
-
Canaccord Genuity Downgrades Ducommun Incorporated (DCO) to Hold
-
Canaccord Genuity Downgrades Cenovus Energy Inc. (CVE) to Hold
-
PhotoMedex (PHMD) to Acquire LCA-Vision (LCAV) for $5.37/Share in Cash
-
Canaccord Boosts PT on Incyte (INCY) to $85; Sees Plenty of Positive Events in 2014
-
Canaccord Genuity Starts Chimerix (CMRX) at Buy
-
Canaccord Genuity Starts Stein Mart Inc. (SMRT) at Buy
-
Canaccord Genuity Downgrades Itron (ITRI) to Hold
-
Canaccord Lifts PT on Marketo (MKTO) to $52; Mid-Term Growth to Remain Firm


